Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] NLMUID: 8707234"" wg kryterium: JN

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 9764
Tytuł:
Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis.
Autorzy:
Niu H; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Ma J; Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Medina-Caliz I; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.
Robles-Diaz M; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.
Bonilla-Toyos E; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Ghabril M; Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Lucena MI; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Alvarez-Alvarez I; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.; Platform for Clinical Research and Clinical Trials IBIMA, Plataforma ISCIII de Investigación Clínica, Madrid, Spain.
Andrade RJ; Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain.; Biomedical Research Network Center for Hepatic and Digestive Diseases (CIBERehd), Carlos III Health Institute, Madrid, Spain.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 886-896. Date of Electronic Publication: 2022 Dec 22.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Failure, Acute*/etiology
Chemical and Drug Induced Liver Injury*/diagnosis
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/etiology
Humans ; Propensity Score ; Adrenal Cortex Hormones/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meta-analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases.
Autorzy:
Hinkson A; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
Lally H; School of Medicine, University of Leeds, Leeds, UK.
Gibson H; School of Medicine, University of Leeds, Leeds, UK.
Jones R; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Rowe IA; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.; Leeds Institute for Medical Research, University of Leeds, Leeds, UK.
Shinkins B; Test Evaluation Group, Leeds Institute for Health Sciences, University of Leeds, Leeds, UK.
Parker R; Leeds Liver Unit, St James' University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Liver Research Group, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 750-762. Date of Electronic Publication: 2023 Jan 17.
Typ publikacji:
Meta-Analysis; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Non-alcoholic Fatty Liver Disease*/pathology
Elasticity Imaging Techniques*
Humans ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Liver/pathology ; Liver Function Tests ; Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Severe colitis in patients with melanoma treated with BRAF/MEK inhibitors.
Autorzy:
Carbonnel F; Service de Gastroentérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris Saclay, Le Kremlin Bicêtre, France.; Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Villejuif, France.
Routier E; Dermatology Unit, Department of Medicine, Institute Gustave Roussy, Villejuif, France.
Lazure T; Laboratoire d'Anatomopathologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
Mussini C; Laboratoire d'Anatomopathologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
Bellanger C; Service de Gastroentérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
Merklen C; Service de Dermatologie, Hôpitaux Civils de Colmar, Colmar, France.
Bejou B; Service de Gastroentérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France.
Buisson A; Service des maladies de l'appareil digestif, CHU Estaing et Inserm U1071, Université Clermont Auvergne, Clermont-Ferrand, France.
Amiot A; Service de Gastroentérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris Saclay, Le Kremlin Bicêtre, France.; Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Villejuif, France.
Meyer A; Service de Gastroentérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris Saclay, Le Kremlin Bicêtre, France.; Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Villejuif, France.
Dong C; Service de Gastroentérologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris Saclay, Le Kremlin Bicêtre, France.; Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Villejuif, France.
Robert C; Université Paris Saclay, Le Kremlin Bicêtre, France.; Dermatology Unit, Department of Medicine, Institute Gustave Roussy, Villejuif, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 792-799. Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/genetics
Skin Neoplasms*/drug therapy
Skin Neoplasms*/etiology
Skin Neoplasms*/pathology
Female ; Humans ; Male ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Mitogen-Activated Protein Kinase Kinases/therapeutic use ; Mutation ; Neoplasm Recurrence, Local/drug therapy ; Protein Kinase Inhibitors/adverse effects ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins B-raf/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: severe colitis induced by targeted therapies in dermato-oncology beyond check point-inhibitors.
Autorzy:
Hammoudi N; Université de Paris, INSERM U1160, EMiLy, Institut de Recherche Saint-Louis, Paris, France.; Gastroenterology Department, AP-HP, Hôpital Saint-Louis, Lariboisière, Paris, France.
Allez M; Université de Paris, INSERM U1160, EMiLy, Institut de Recherche Saint-Louis, Paris, France.; Gastroenterology Department, AP-HP, Hôpital Saint-Louis, Lariboisière, Paris, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 808-809.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Colitis*/chemically induced
Colitis*/drug therapy
Antineoplastic Agents*/adverse effects
Humans ; Skin Neoplasms/drug therapy
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects.
Autorzy:
Hwang I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Ji SC; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Oh J; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Kim H; Onconic Therapeutics Inc., Seoul, Republic of Korea.
Cha H; Onconic Therapeutics Inc., Seoul, Republic of Korea.
Kim J; Onconic Therapeutics Inc., Seoul, Republic of Korea.
Lee CS; Jeil Pharmaceutical CO., LTD., Seoul, Republic of Korea.
Yu KS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 763-772. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Potassium*
Esomeprazole*
Humans ; Male ; Healthy Volunteers ; Double-Blind Method ; Gastrins ; Dose-Response Relationship, Drug ; Administration, Oral
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: Interdisciplinary and multidisciplinary approach to malnutrition in patients with inflammatory bowel disease.
Autorzy:
Speedy AP; Department of Nutrition and Dietetics, Christchurch Hospital, Christchurch, New Zealand.
Wall CL; Department of Nutrition and Dietetics, Christchurch Hospital, Christchurch, New Zealand.; Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 907-908.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Malnutrition*/diagnosis
Malnutrition*/etiology
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/therapy
Humans
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease.
Autorzy:
Magherman L; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Van Parys R; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Pauwels NS; Knowledge Center for Health Ghent, Ghent University and Ghent University Hospital, Ghent, Belgium.
Verhelst X; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Devisscher L; Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Van Vlierberghe H; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Geerts A; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Lefere S; Hepatology Research Unit, Dpt. Internal Medicine and Pediatrics, Liver Research Center Ghent, Ghent University, Ghent, Belgium.; Gut-Liver Immunopharmacology Unit, Department of Basic and Applied Medical Sciences, Liver Research Center Ghent, Ghent University, Ghent, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 820-836. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*
Liver Neoplasms*/etiology
Non-alcoholic Fatty Liver Disease*/epidemiology
Humans ; Alcohol Drinking/adverse effects ; Cross-Sectional Studies ; Fibrosis ; Liver Cirrhosis/etiology ; Liver Cirrhosis/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease.
Autorzy:
Khan N; Department of Gastroenterology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.; Division of Gastroenterology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Mahmud N; Department of Gastroenterology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.; Division of Gastroenterology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Patel M; Department of Gastroenterology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
Sundararajan R; Department of Gastroenterology, Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
Reinisch W; Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 800-807. Date of Electronic Publication: 2023 Jan 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/complications
Opportunistic Infections*/epidemiology
Humans ; SARS-CoV-2 ; Retrospective Studies ; Tumor Necrosis Factor Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours-Authors' reply.
Autorzy:
Dahl E; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.
Abed O; Department of Gastroenterology, Odense University Hospital, Odense, Denmark.; Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Agnholt J; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Bjerrum J; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.
Dige A; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Kjeldsen J; Department of Gastroenterology, Odense University Hospital, Odense, Denmark.; Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Svane I; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Donia M; Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Seidelin J; Department of Gastroenterology, Copenhagen University Hospital, Herlev, Denmark.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 918-919.
Typ publikacji:
Letter; Comment
MeSH Terms:
Gastrointestinal Diseases*
Neoplasms*/drug therapy
Communicable Diseases*
Cytomegalovirus Infections*/diagnosis
Cytomegalovirus Infections*/drug therapy
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Review article: Functional dyspepsia-a gastric disorder, a duodenal disorder or a combination of both?
Autorzy:
Broeders BWLCM; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Carbone F; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Balsiger LM; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
Schol J; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Raymenants K; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Huang I; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
Verheyden A; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
Vanuytsel T; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Tack J; Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.; Faculty of Medicine, KU Leuven, Leuven, Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 851-860. Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Dyspepsia*/drug therapy
Dyspepsia*/diagnosis
Duodenal Diseases*
Eosinophilia*/complications
Humans ; Duodenum ; Eosinophils
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stromal vascular fraction with platelet-rich plasma injection during surgery is feasible and safe in treatment-refractory perianal fistulising Crohn's disease: A pilot study.
Autorzy:
Arkenbosch JHC; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Ruler O; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
Dwarkasing RS; Department of Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Fuhler GM; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Schouten WR; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.
van Oud-Alblas MB; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.
de Graaf EJR; Department of Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.
de Vries AC; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 783-791. Date of Electronic Publication: 2022 Dec 26.
Typ publikacji:
Journal Article
MeSH Terms:
Crohn Disease*/complications
Crohn Disease*/surgery
Rectal Fistula*/diagnostic imaging
Rectal Fistula*/etiology
Rectal Fistula*/surgery
Platelet-Rich Plasma*
Humans ; Female ; Male ; Treatment Outcome ; Pilot Projects ; Stromal Vascular Fraction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: should we abandon FIB-4 to characterise non-invasively patients with NAFLD?
Autorzy:
Pugliese N; Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.
Franchellucci G; Division of Internal Medicine and Hepatology, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
Viganò M; Gastroenterology, Hepatology and Transplantation Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 920-921.
Typ publikacji:
Letter; Comment
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Humans ; Risk Factors ; Liver Cirrhosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: risankizumab - ready to break ceilings?
Autorzy:
Ferrante M; Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 909-910.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Antibodies, Monoclonal*/therapeutic use
Psoriasis*/drug therapy
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: trial of antitubercular therapy for diagnosing Crohn's disease in LMICs-double whammy?
Autorzy:
Gupta A; Massachusetts General Hospital, Boston, Massachusetts, USA.
Kedia S; All India Institute of Medical Sciences, New Delhi, India.
Ahuja V; All India Institute of Medical Sciences, New Delhi, India.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 815-816.
Typ publikacji:
Letter; Comment
MeSH Terms:
Crohn Disease*/diagnosis
Crohn Disease*/drug therapy
Humans ; Developing Countries ; Double-Blind Method
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: deja vu all over again - let the P-CAB wars begin. Authors' reply.
Autorzy:
Hwang I; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 914-915.
Typ publikacji:
Editorial; Comment
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates.
Autorzy:
Teng YX; Hepatobiliary Surgery Department, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Guangxi Medical University Cancer Hospital, Nanning, China.
Zhang WG; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chan AW; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
Chong CCN; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
Serenari M; Hepatobiliary Surgery and Transplant Unit, Azienda Ospedaliero-Universitaria di Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Wang YY; Hepatopancreatobiliary Surgery Department I, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital and Institute, Beijing, China.
Peng N; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Huang T; Department of Hepatobiliary Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Lu SD; Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.
Liang ZY; Department of Hepatobiliary Surgery, The First People's Hospital of Nanning, Nanning, China.
Ma L; Hepatobiliary Surgery Department, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Guangxi Medical University Cancer Hospital, Nanning, China.
Zhong JH; Hepatobiliary Surgery Department, Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Guangxi Medical University Cancer Hospital, Nanning, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 810-812.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/surgery
Liver Neoplasms*/pathology
Radiofrequency Ablation*
Catheter Ablation*
Humans ; Hepatectomy ; Treatment Outcome ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: should we abandon FIB-4 to characterise noninvasively patients with NAFLD? Authors' reply.
Autorzy:
Henry L; Inova Medicine, Inova Health System, Falls Church, Virginia, USA.; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Center for Outcomes Research in Liver Diseases, Washington, District of Columbia, USA.
Younossi Z; Inova Medicine, Inova Health System, Falls Church, Virginia, USA.; Liver and Obesity Research Program, Inova Health System, Falls Church, Virginia, USA.; Center for Liver Diseases, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 922-923.
Typ publikacji:
Letter; Comment
MeSH Terms:
Non-alcoholic Fatty Liver Disease*/diagnosis
Humans ; Risk Factors ; Liver Cirrhosis
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates - authors' reply.
Autorzy:
Tong Y; Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.
Chang DH; Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Xiao YD; Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (7), pp. 813-814.
Typ publikacji:
Letter; Comment
MeSH Terms:
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/surgery
Radiofrequency Ablation*
Catheter Ablation*
Humans ; Hepatectomy ; Treatment Outcome ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Meta-analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm.
Autorzy:
Hamilton P; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Buhler K; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
MacDonald JK; Alimentiv Inc., London, Ontario, Canada.
Kaplan GG; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Seow CH; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Lu C; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Novak KL; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Andrews CN; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
Singh S; Division of Gastroenterology, University of California San Diego, San Diego, California, USA.
Jairath V; Alimentiv Inc., London, Ontario, Canada.; Division of Gastroenterology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
Panaccione R; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ma C; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alimentiv Inc., London, Ontario, Canada.; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Apr; Vol. 57 (8), pp. 837-850. Date of Electronic Publication: 2023 Feb 24.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Colitis, Microscopic*/drug therapy
Colitis, Collagenous*/drug therapy
Adult ; Humans ; Budesonide/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 9764

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies